Loading…
biote Corp. is projected to rise to $2.50 by 2027, a +25% move from its current price of $2.00. BTMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.93 | $2.00 | $2.07 | -0.07% |
| May 30 | $1.90 | $2.00 | $2.10 | -0.13% |
| May 31 | $1.88 | $2.00 | $2.12 | -0.20% |
| Jun 1 | $1.86 | $1.99 | $2.14 | -0.26% |
| Jun 2 | $1.85 | $1.99 | $2.15 | -0.33% |
| Jun 3 | $1.83 | $1.99 | $2.17 | -0.39% |
| Jun 4 | $1.82 | $1.99 | $2.18 | -0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.82 | $1.99 | $2.18 | -0.46% |
| Week 2 | $1.74 | $1.98 | $2.25 | -0.91% |
| Week 3 | $1.69 | $1.97 | $2.31 | -1.36% |
| Week 4 | $1.64 | $1.96 | $2.35 | -1.81% |
| Week 5 | $1.60 | $1.95 | $2.39 | -2.26% |
| Week 6 | $1.56 | $1.95 | $2.43 | -2.71% |
| Week 7 | $1.53 | $1.94 | $2.46 | -3.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
Biote Method is a comprehensive end-to-end practice-building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.
biote Corp. trades under the symbol BTMD and operates in the Healthcare sector.
Current price: $1.99. Market cap: $70.75M. Rank: 4434.
Forecast-based outlook is constructive over the long term, with the 2026 average price at $1.99 and a path of rising averages toward 2030 and beyond, including a 2030 average of $3.05 and a 2050 average of $10.46 with a 2050 maximum of $21.20.
A major floor 35.0% below — a decisive break under it would weaken the trend.
The nearest floor, 4.5% below — buyers have tended to step in here.
The nearest ceiling, 14.0% above — a clean break opens room to run.
A major ceiling 21.7% above — clearing it would confirm fresh momentum.
Key BTMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BTMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.02 | Sell | $1.99 | Buy |
| MA 10 | $1.99 | Buy | $2.02 | Sell |
| MA 20 | $2.09 | Sell | $2.04 | Sell |
| MA 50 | $1.87 | Buy | $2.00 | Sell |
| MA 100 | $2.01 | Sell | $2.11 | Sell |
| MA 200 | $2.45 | Sell | $2.52 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.46 | Neutral |
| Stoch RSI (14) | 35.49 | Neutral |
| CCI (20) | -59.95 | Neutral |
| Williams %R (14) | -70.00 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -8.26 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 30.00 | Neutral |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 48.42 | Neutral |
| Momentum (10) | -0.20 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 1.99 | Buy |
| ADX (14) | 17.36 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) is 50. The 50-day simple moving average is $1.85 and the 200-day simple moving average is $2.46. Support is at $1.79 and resistance at $2.28. The 30-day price range runs from $1.59 to $2.49.
Given this setup, near-term movement may continue to oscillate between support and resistance, with a bias toward stability near the current level as momentum remains neutral.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.30 | $2.00 | $2.62 | 0% | Neutral | |
| $1.93 | $2.50 | $3.44 | +25% | Bullish | |
| $2.09 | $2.80 | $4.03 | +40% | Bullish | |
| $2.13 | $2.93 | $4.36 | +46% | Bullish | |
| $2.18 | $3.08 | $4.71 | +54% | Bullish | |
| $2.05 | $2.97 | $4.67 | +49% | Bullish | |
| $2.06 | $3.06 | $4.91 | +53% | Bullish | |
| $2.22 | $3.36 | $5.51 | +68% | Bullish | |
| $2.67 | $4.12 | $6.88 | +106% | Bullish | |
| $3.05 | $4.81 | $8.16 | +140% | Bullish | |
| $3.19 | $5.51 | $10.04 | +175% | Bullish | |
| $5.28 | $10.70 | $21.62 | +435% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.30 | $2.00 | $2.34 | +0.00% |
| June 2026 | $1.60 | $1.88 | $2.28 | -5.83% |
| July 2026 | $1.58 | $1.88 | $2.32 | +0.04% |
| August 2026 | $1.60 | $1.93 | $2.41 | +2.25% |
| September 2026 | $1.55 | $1.87 | $2.36 | -2.81% |
| October 2026 | $1.52 | $1.86 | $2.36 | -0.88% |
| November 2026 | $1.60 | $1.97 | $2.52 | +5.93% |
| December 2026 | $1.64 | $2.02 | $2.62 | +2.91% |
Click any year to see its month-by-month BTMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BTMD to range from $1.30 to $2.62 through 2026. The $2.00 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BTMD price prediction for 2027 points to an average of $2.50 (low $1.93, high $3.44) — a potential gain of +25% on today's $2.00. Buyers look set to stay in control over this stretch.
In 2028, BTMD is projected to trade between $2.09 and $4.03, averaging $2.80 — a potential gain of +40% from today's $2.00. That is up +12% on the projected 2027 average. Momentum favours further upside here.
biote Corp.'s 2029 outlook centres on $2.93, within a $2.13 to $4.36 range. That is up +5% on the projected 2028 average. That marks a +46% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, BTMD could reach as high as $4.71, with a base case around $3.08 and support toward $2.18 — roughly +54% from $2.00. Momentum favours further upside here.
Expect BTMD to range from $2.05 to $4.67 through 2031. The $2.97 average target implies a +49% move from current prices. That is -3% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The BTMD price prediction for 2032 points to an average of $3.06 (low $2.06, high $4.91) — a potential gain of +53% on today's $2.00. Momentum favours further upside here.
In 2033, BTMD is projected to trade between $2.22 and $5.51, averaging $3.36 — a potential gain of +68% from today's $2.00. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
biote Corp.'s 2034 outlook centres on $4.12, within a $2.67 to $6.88 range. That is up +23% on the projected 2033 average. That marks a +106% change versus current levels. Momentum favours further upside here.
By 2035, BTMD could reach as high as $8.16, with a base case around $4.81 and support toward $3.05 — roughly +140% from $2.00. Buyers look set to stay in control over this stretch.
Expect BTMD to range from $3.19 to $10.04 through 2040. The $5.51 average target implies a +175% move from current prices. That is up +15% on the projected 2035 average. Momentum favours further upside here.
The BTMD price prediction for 2050 points to an average of $10.70 (low $5.28, high $21.62) — a potential gain of +435% on today's $2.00. Buyers look set to stay in control over this stretch.
Investing $1,000 in BTMD today (≈ 500 BTMD) could be worth
$5,350.01
+$4,350.01 (+435%) by 2050 · US Dollar
Based on the average projected BTMD price of $10.7 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BTMDwould be worth at today's price.
$1,000 invested in BTMD on May 27, 2025 (≈ 245.098044 BTMD) would be worth
$490.2
-$509.8 (-51.0%) today · 0.49× · US Dollar
Based on a BTMD entry price of $4.08 vs. today's $2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.1 | $952.38 | -4.8% |
| 1 month ago | $2.27 | $881.06 | -11.9% |
| 3 months ago | $2.15 | $930.23 | -7.0% |
| 6 months ago | $2.7 | $739.37 | -26.1% |
| 1 year ago | $4.08 | $490.2 | -51.0% |
| All time (5.0y) ago | $9.8 | $204.08 | -79.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BTMD forecast.
Our base-case forecast reaches $4.00 around 2034.
Implied market cap at $4.00: $121.33M
The multi-year forecast shows a bullish trajectory after 2026. The 2026 forecast features a min of $1.30, an avg of $1.99, and a max of $2.60, with ROI 0 and sentiment NEUTRAL.
From 2027 onward, the path generally trends higher: 2027 avg $2.47 (ROI 24.3), 2028 avg $2.80 (ROI 40.7), 2029 avg $2.89 (ROI 45.4), and 2030 avg $3.05 (ROI 53.2).
Further years show continued gains: 2031 avg $2.96 (ROI 48.5), 2032 avg $2.99 (ROI 50.3), 2033 avg $3.33 (ROI 67.3), 2034 avg $4.10 (ROI 106.2), and 2035 avg $4.71 (ROI 136.8).
Longer-term projections reach 2040 with avg $5.44 (ROI 173.6) and max $9.95, and 2050 with avg $10.46 (ROI 425.6) and max $21.20, all under a bullish sentiment. The figures reflect a rising-price trajectory but remain estimates, not guarantees, and come with notable volatility.
Tap a question to reveal the answer.
2030 min $2.15; avg $3.05; max $4.68; ROI 53.2; sentiment BULLISH.
Forecasts indicate a bullish trajectory in 2027–2050 with rising averages and max values, though 2026 is NEUTRAL (avg $1.99; min $1.30; max $2.60; ROI 0) and the longer horizon includes notable volatility.
Yes. The forecast shows max prices of $5.47 in 2033, $6.87 in 2034, and $8.02 in 2035.
2040 avg $5.44; max $9.95; ROI 173.6; sentiment BULLISH.
2050 min $5.13; avg $10.46; max $21.20; ROI 425.6; sentiment BULLISH.
biote Corp. Community Discussion
0Share your biote Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.